153 related articles for article (PubMed ID: 31385546)
1. Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma.
Gay S; Monti E; Trambaiolo Antonelli C; Mora M; Spina B; Ansaldo G; Teliti M; Comina M; Conte L; Minuto M; Varaldo E; Zupo S; Massa B; Morbelli S; Giusti M
Future Oncol; 2019 Aug; 15(24s):13-19. PubMed ID: 31385546
[TBL] [Abstract][Full Text] [Related]
2. Long-term disease control and high clinical benefit in a patient with advanced thyroid cancer treated with lenvatinib.
Muratori L; Sperone P; Scagliotti GV
Future Oncol; 2019 Aug; 15(24s):3-6. PubMed ID: 31385526
[TBL] [Abstract][Full Text] [Related]
3. Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
Yang J; Gong R; Ma Y; Gao J; Li Z; Zhu J; Gong Y
Front Endocrinol (Lausanne); 2021; 12():654638. PubMed ID: 33897621
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of Lenvatinib for Thyroid Cancer with Lung Metastases - Report of a Case].
Nagashima S; Matsuo S; Takahashi M; Umemoto Y; Hirano T; Enomoto K; Sakurai K; Amano S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2121-2123. PubMed ID: 28133242
[TBL] [Abstract][Full Text] [Related]
5. Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Danilovic DLS; Castro G; Roitberg FSR; Vanderlei FAB; Bonani FA; Freitas RMC; Coura-Filho GB; Camargo RY; Kulcsar MA; Marui S; Hoff AO
Arch Endocrinol Metab; 2018 Jun; 62(3):370-375. PubMed ID: 29791660
[TBL] [Abstract][Full Text] [Related]
6. Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.
Sheu NW; Jiang HJ; Wu CW; Chiang FY; Chiou HC; Hsiao PJ
World J Surg Oncol; 2019 May; 17(1):84. PubMed ID: 31103041
[TBL] [Abstract][Full Text] [Related]
7. Differentiated thyroid carcinoma: Incremental diagnostic value of
Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
[TBL] [Abstract][Full Text] [Related]
8. Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.
Mahajan P; Dawrant J; Kheradpour A; Quintanilla NM; Lopez ME; Orth RC; Athanassaki I; Venkatramani R
Thyroid; 2018 Nov; 28(11):1450-1454. PubMed ID: 30226445
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the QTc interval during lenvatinib treatment in radioiodine-refractory differentiated thyroid cancer: reports from the real-life clinical practice.
Marina M; Serra MF; Rio PD; Ceresini G
Future Oncol; 2019 Aug; 15(24s):7-12. PubMed ID: 31418590
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant lenvatinib for inoperable thyroid cancer: A case report and literature review.
Alshehri K; Alqurashi Y; Merdad M; Samargandy S; Daghistani R; Marzouki H
Cancer Rep (Hoboken); 2022 Feb; 5(2):e1466. PubMed ID: 34105309
[TBL] [Abstract][Full Text] [Related]
11. Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma.
Rodia R; Marini S; Pani F; Boi F; Mariotti S
Future Oncol; 2019 Aug; 15(24s):35-40. PubMed ID: 31385535
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Management of an Elderly Patient With Metastatic Radioiodine-Resistant Differentiated Thyroid Cancer in a Rural Community, Remote From Specialist Oncology Services.
Wybrew R; Loynd M; Wybrew M; Samuel L
Front Endocrinol (Lausanne); 2020; 11():581014. PubMed ID: 33597920
[TBL] [Abstract][Full Text] [Related]
13. [A Case of Long-Term Survival of Anaplastic Transformation of Thyroid Cancer in Lymph Node Metastasis Due to Radiation Therapy and Lenvatinib].
Masuda G; Hori T; Tani N; Sakimura C; Teramura K; Tendo M; Nakata B; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2021 Jan; 48(1):148-150. PubMed ID: 33468750
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.
Goto H; Kiyota N; Otsuki N; Imamura Y; Chayahara N; Suto H; Nagatani Y; Toyoda M; Mukohara T; Nibu KI; Kasahara T; Ito Y; Miya A; Hirokawa M; Miyauchi A; Minami H
Auris Nasus Larynx; 2018 Dec; 45(6):1249-1252. PubMed ID: 29779695
[TBL] [Abstract][Full Text] [Related]
15. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
Masaki C; Sugino K; Saito N; Saito Y; Tanaka T; Ogimi Y; Maeda T; Osaku T; Akaishi J; Hames KY; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2017 Aug; 64(8):819-826. PubMed ID: 28659544
[TBL] [Abstract][Full Text] [Related]
16. Lenvatinib: Role in thyroid cancer and other solid tumors.
Cabanillas ME; Habra MA
Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514
[TBL] [Abstract][Full Text] [Related]
17. Utility of fluorine-18-fluorodeoxyglucose positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels.
Muros MA; Llamas-Elvira JM; Ramírez-Navarro A; Gómez MJ; Rodríguez-Fernández A; Muros T; López de la Torre M; Becerra A; Carreras JL
Am J Surg; 2000 Jun; 179(6):457-61. PubMed ID: 11004330
[TBL] [Abstract][Full Text] [Related]
18. Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report.
Kitamura M; Hayashi T; Suzuki C; Hirano S; Tateya I; Kishimoto Y; Omori K
World J Surg Oncol; 2017 Jan; 15(1):24. PubMed ID: 28088233
[TBL] [Abstract][Full Text] [Related]
19. Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.
Kiyota N; Robinson B; Shah M; Hoff AO; Taylor MH; Li D; Dutcus CE; Lee EK; Kim SB; Tahara M
Thyroid; 2017 Sep; 27(9):1135-1141. PubMed ID: 28665259
[TBL] [Abstract][Full Text] [Related]
20. Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib.
Porcelli T; Sessa F; Gambale C; Luongo C; Salvatore D
Future Oncol; 2019 Aug; 15(24s):21-25. PubMed ID: 31411063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
